Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA and prognosis in multiple sclerosis

B Runmarker1, T Martinsson, J Wahlström

  • 1Department of Neurology, Sahlgren's Hospital, Göteborg, Sweden.

Journal of Neurology
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can biofeedback training in combination with ergonomic information reduce pain among young adult computer users with neck and upper extremity symptoms? - A randomized controlled intervention study.

Applied ergonomics·2023
Same author

Can sensation of cold hands predict Raynaud's phenomenon or paraesthesia?

Occupational medicine (Oxford, England)·2018
Same author

Diffusion tensor imaging in multiple sclerosis at different final outcomes.

Acta neurologica Scandinavica·2017
Same author

Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID.

Bone marrow transplantation·2017
Same author

Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Clinical and experimental immunology·2015
Same author

Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome.

Clinical and experimental immunology·2014

Human leukocyte antigen (HLA) DR15,DQ6 is associated with multiple sclerosis (MS) risk but not prognosis. However, HLA-DR17,DQ2 and DR1,DQ5 may indicate a more severe disease course in MS patients.

Area of Science:

  • Immunogenetics
  • Neurology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Human leukocyte antigen (HLA) genes, particularly HLA-DR and DQ, are known risk factors for MS.
  • Longitudinal studies are crucial for understanding gene-disease associations and prognosis.

Purpose of the Study:

  • To investigate the association between specific HLA-DR and DQ haplotypes and the risk and prognosis of multiple sclerosis (MS).
  • To analyze gene frequencies in a well-defined MS incidence cohort with extensive follow-up.
  • To assess the influence of mortality and sampling bias on the study findings.

Main Methods:

  • Analysis of HLA-DR and DQ genotypes in a 25-year longitudinal MS incidence cohort.

Related Experiment Videos

  • Statistical methods to account for sampling bias due to mortality.
  • Comparison of HLA haplotype frequencies between different MS subtypes and disease severity quartiles.
  • Main Results:

    • A significant association between MS and the HLA-DR15,DQ6 haplotype was confirmed, but it did not impact disease prognosis.
    • No significant difference in HLA haplotype frequencies was observed between relapsing-remitting MS and primary chronic progressive MS.
    • The HLA-DR17,DQ2 haplotype was over-represented in patients with the most malignant MS course.
    • The less frequent HLA-DR1,DQ5 haplotype also showed a trend towards association with poorer prognosis.

    Conclusions:

    • HLA-DR15,DQ6 is a risk factor for MS but does not predict disease severity or progression.
    • Specific HLA haplotypes, such as DR17,DQ2 and DR1,DQ5, may be associated with a more aggressive form of multiple sclerosis.
    • Longitudinal cohort studies, with careful consideration of biases, are valuable for immunogenetic and prognostic research in MS.